Chemokine-induced cell death in CCR5-expressing neuroblastoma cells

Laetitia Cartier1, Michel Dubois-Dauphin, Oliver Hartley

  • 1Biology of Ageing Laboratory, Department of Geriatrics, Geneva University Hospitals, 1225 Chêne-Bourg, Switzerland.

Insights

Chemokine receptor CCR5 acts as a death receptor in neuronal cells, triggering apoptosis and enhancing microglial-mediated killing. This suggests CCR5

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • The role of C-C chemokine receptor type 5 (CCR5) in neurons is largely unknown.
  • CCR5 is a receptor implicated in immune cell trafficking and inflammatory responses.

Purpose of the Study:

  • To investigate the function of CCR5 in neuronal cells.
  • To determine if CCR5 mediates cell death in neuronal lineage cells.

Main Methods:

  • Generation of SH-SY5Y neuroblastoma cells engineered to express CCR5.
  • Treatment of CCR5-expressing and control cells with CCR5 ligands.
  • Assessment of apoptosis via caspase-3 activation and inhibition.
  • Evaluation of microglial-mediated cell killing.

Main Results:

  • CCR5 ligands induced apoptosis specifically in CCR5-expressing neuroblastoma cells, not in control cells or fibroblasts.
  • Caspase-3 activation confirmed an apoptotic pathway, preventable by a caspase-3 inhibitor.
  • Activated microglia exhibited more rapid and extensive killing of CCR5-expressing neuroblastoma cells.

Conclusions:

  • CCR5 may function as a death receptor in cells of neuronal origin.
  • CCR5's role in neuronal apoptosis suggests involvement in inflammatory neurodegeneration.